1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Global Plasma Therapeutics Market 2015-2019

  • August 2015
  • 71 pages
  • Infiniti Research Limited
Report ID: 3170229

Summary

Table of Contents

Search Inside

About plasma and plasma therapeutics
Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases. The separation of plasma from the blood is done by a process known as plasmapheresis. Plasma therapeutics are utilized in the treatment of rare, life-threatening, chronic, and genetic diseases, such as immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, and infectious diseases such as tetanus, hepatitis, and rabies.

Technavio's analysts forecast the global plasma therapeutics market to grow at a CAGR of 12.10% over the period 2014-2019.

Covered in this report
The report covers the present scenario and the growth prospects of the global plasma therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.

Technavio's report, Global Plasma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global plasma therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- Baxter
- CSL Behring
- Grifols Therapeutics
- Octapharma

Other prominent vendors
- Abeona Therapeutics
- ADMA Biologics
- Amag Pharmaceuticals
- Antares Pharma
- BioDelivery Sciences
- Bio Products Laboratory
- Biota Pharmaceuticals
- Biotest Pharmaceuticals
- China Biologic Products
- Depomed
- Emergent BioSolutions
- Ethicon
- Flamel Technologies
- Kamada
- Kedrion
- King Pharmaceuticals
- Nektar Therapeutics
- OMRIX Biopharmaceuticals
- ProMetic Life Sciences
- Rockwell Medical
- The Medicines
- ZymoGenetics

Key market driver
- Growing demand for IVIG therapies
- For a full, detailed list, view our report

Key market challenge
- High cost of therapy
- For a full, detailed list, view our report

Key market trend
- Patient assistance programs
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Amrita helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Hemophilia A and B – Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • September 2017
  • by GlobalData

Hemophilia A and B are rare recessive X-linked genetic deficiencies in the blood clotting factors VIII and IX, respectively, and are characterized by the failure of blood to form normal clots after damage ...

Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need

  • $ 6995
  • Industry report
  • August 2017
  • by GBI Research

Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant ...

Epiomic Epidemiology Series: Sickle Cell Disease Forecast in 10 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • July 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Sickle Cell Disease in 10 Major Markets Sickle cell disease (SCD) is a term comprising clinically relevant haemoglobinopathies caused ...


Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics in the US - Forecast

  • September 2017
    9 pages
  • Blood Disease  

    Factor VIII  

  • United States  

View report >

Blood Disease and HIV AIDS Statistics in Africa and Malawi

  • September 2017
    22 pages
  • Blood Disease  

    HIV AIDS  

    Infectious Dise...  

  • Africa  

    Malawi  

View report >

Dysfunction Drug Market and Blood Disease Statistics in the UK

  • September 2017
    7 pages
  • Dysfunction Dru...  

    Blood Disease  

  • United Kingdom  

View report >

Related Market Segments :

Blood Disease
Therapy

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.